Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer

被引:255
作者
Ueno, M [1 ]
Oya, M [1 ]
Azekura, K [1 ]
Yamaguchi, T [1 ]
Muto, T [1 ]
机构
[1] Canc Inst Hosp, Dept Surg Gastroenterol, Koto, Tokyo 1358550, Japan
关键词
D O I
10.1002/bjs.4975
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Lateral lymph node metastases occur in some patients with low rectal cancer and may cause local recurrence after total mesorectal excision. The aims of this study were to identify risk factors for lateral node metastases in patients with pathological turnout (pT) stage 3 or pT4 low rectal adenocarcinoma, and to evaluate the prognostic significance of lateral node metastases. Methods: A retrospective analysis was performed of the outcome of 237 patients with pT3 or pT4 low rectal adenocarcinoma who underwent R0 resection with systematic lateral node dissection. Results: Lateral lymph node metastases were found in 41 patients (17.3 per cent). Increased risk of lateral lymph node metastases was associated with a distal tumour margin close to the anal margin, histological type other than well or moderately differentiated adenocarcinoma, and the presence of mesenteric lymph node metastases. Patients with lateral node metastases had a significantly shorter postoperative survival (5-year survival rate 42 versus 71.6 per cent; P < 0.001) and an increased risk of local recurrence (44 versus 11.7 per cent; P < 0.001) compared with those without lateral node metastases. Conclusion: Tumour site, histological type and the presence of mesenteric lymph node metastasis are factors predicting the risk of lateral node metastasis. The poor prognosis of patients with lateral lymph node metastases after systematic lateral dissection suggests the need for adjuvant therapy.
引用
收藏
页码:756 / 763
页数:8
相关论文
共 25 条
[1]   Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery [J].
Birbeck, KF ;
Macklin, CP ;
Tiffin, NJ ;
Parsons, W ;
Dixon, MF ;
Mapstone, NP ;
Abbott, CR ;
Scott, N ;
Finan, PJ ;
Johnston, D ;
Quirke, P .
ANNALS OF SURGERY, 2002, 235 (04) :449-457
[2]  
ENKER WE, 1995, J AM COLL SURGEONS, V181, P335
[3]  
Fleming I.D., 1997, American Joint Committee on Cancer: AJCC Cancer Staging Manual, V5th
[4]  
Gray R, 2001, LANCET, V358, P1291
[5]   Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients [J].
Havenga, K ;
Enker, WE ;
Norstein, J ;
Moriya, Y ;
Heald, RJ ;
van Houwelingen, HC ;
van de Velde, CJH .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (04) :368-374
[6]  
HEALD RJ, 1986, LANCET, V1, P1479
[7]   Rectal cancer - The Basingstoke experience of total mesorectal excision, 1978-1997 [J].
Heald, RJ ;
Moran, BJ ;
Ryall, RDH ;
Sexton, R ;
MacFarlane, JK .
ARCHIVES OF SURGERY, 1998, 133 (08) :894-898
[8]  
Hida J, 1997, J AM COLL SURGEONS, V184, P475
[9]   AN ANALYSIS OF SURVIVAL AND VOIDING, SEXUAL FUNCTION AFTER WIDE ILIOPELVIC LYMPHADENECTOMY IN PATIENTS WITH CARCINOMA OF THE RECTUM, COMPARED WITH CONVENTIONAL LYMPHADENECTOMY [J].
HOJO, K ;
SAWADA, T ;
MORIYA, Y .
DISEASES OF THE COLON & RECTUM, 1989, 32 (02) :128-133
[10]   LYMPHATIC SPREAD AND ITS PROGNOSTIC VALUE IN PATIENTS WITH RECTAL-CANCER [J].
HOJO, K ;
KOYAMA, Y ;
MORIYA, Y .
AMERICAN JOURNAL OF SURGERY, 1982, 144 (03) :350-354